Detalles de la búsqueda
1.
The high identity of the Trypanosoma cruzi Group-I of trans-sialidases points them as promising vaccine immunogens.
Proteins
; 91(10): 1444-1460, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37323089
2.
Systemic inflammatory Th1 cytokines during Trypanosoma cruzi infection disrupt the typical anatomical cell distribution and phenotypic/functional characteristics of various cell subsets within the thymus.
Microbes Infect
; : 105337, 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615883
3.
Assessment of a combined treatment with a therapeutic vaccine and benznidazole for the Trypanosoma cruzi chronic infection.
Acta Trop
; 229: 106334, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101415
4.
Immunization With Lipopolysaccharide-Activated Dendritic Cells Generates a Specific CD8+ T Cell Response That Confers Partial Protection Against Infection With Trypanosoma cruzi.
Front Cell Infect Microbiol
; 12: 897133, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35903201
5.
Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection.
Vaccine
; 40(15): 2311-2323, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279330
6.
Chagas disease reactivation in rheumatologic patients: association with immunosuppressive therapy and humoral response.
Clin Rheumatol
; 40(7): 2955-2963, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33438080
7.
Activation of PPARγ reduces N-acetyl-cysteine -induced hypercorticoidism by down-regulating MC2R expression into adrenal glands.
Free Radic Biol Med
; 156: 137-143, 2020 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574682
Resultados
1 -
7
de 7
1
Próxima >
>>